Product NDC: | 58118-5522 |
Proprietary Name: | FENOFIBRATE |
Non Proprietary Name: | FENOFIBRATE |
Active Ingredient(s): | 160 mg/1 & nbsp; FENOFIBRATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 58118-5522 |
Labeler Name: | Clinical Solutions Wholesale |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076509 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100201 |
Package NDC: | 58118-5522-0 |
Package Description: | 1 TABLET in 1 PACKET (58118-5522-0) |
NDC Code | 58118-5522-0 |
Proprietary Name | FENOFIBRATE |
Package Description | 1 TABLET in 1 PACKET (58118-5522-0) |
Product NDC | 58118-5522 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FENOFIBRATE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100201 |
Marketing Category Name | ANDA |
Labeler Name | Clinical Solutions Wholesale |
Substance Name | FENOFIBRATE |
Strength Number | 160 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |